Oral suspension of prednisolone acetate
US7799331B2 · kind B2 · utility
7Cited by
14References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 2006 |
| Grant date | Sep 21, 2010 |
| Priority date | — |
| Expiry date | Oct 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel oral suspension formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent. The present invention further provides a method of treating patients in need of prednisolone with the novel formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.